Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2002
07/09/2002US6416997 Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery
07/09/2002US6416992 Using rotation bottles; transfection; culture product
07/09/2002US6416991 Genetic engineered protein
07/09/2002US6416990 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/09/2002US6416989 Isolated polypeptide
07/09/2002US6416987 Mutants of thymidylate synthase and uses thereof
07/09/2002US6416986 Converts 4-chloroacetoacetate ester to (s)-4-halo-3-hydroxy butyrate; does not substantially dehydrogenate optical isomers of 4-halo-3-hydroxy-butyrate ester; uses reduced beta-nicotinamide adenine dinucleotide as electron donor
07/09/2002US6416985 DNA encoding mannose 6-phosphate reductase and recombinants produced therefrom
07/09/2002US6416984 Human DNA mismatch repair proteins
07/09/2002US6416976 TrpS
07/09/2002US6416975 Human glycine transporter type 2
07/09/2002US6416974 Tango 71 nucleic acids
07/09/2002US6416973 Nucleic acids encoding mammalian cell membrane protein MDL-1
07/09/2002US6416972 Purified hybrid nucleic acid
07/09/2002US6416971 Soluble, single chain t cell receptor encoded by specified nucleic acid sequence
07/09/2002US6416966 Contacting target protein with candidate agent at first and second concentrations and determining level of activity of target protein at each, wherein difference between levels of activity indicates candidate agent modulates activity
07/09/2002US6416959 Providing cells containing luminescent reporter molecules in array of locations, treating with reagents, imaging numerous cells in each location, converting signals into digital data, determining distribution, environment or activity
07/09/2002US6416957 Method for modulating process mediated by farnesoid activated receptors
07/09/2002US6416956 Screening for and/or diagnosing breast cancer by obtaining cell sample from patient and determining whether bp1 is overexpressed by said cell sample as compared to normal cells
07/09/2002US6416953 Hybridization of polynucleotides conjugated with chromo-phores and fluorophores to generate donor-to-donor energy transfer system
07/09/2002US6416951 Screening for functional antisense agents
07/09/2002US6416950 Linking nucleic acid reverse transcription primer which is bound to peptide acceptor to rna, translating rna to produce protein product covalently bound to primer, reverse transcribing rna to produce dna-protein fusion
07/09/2002US6416949 Composition comprising first solid support linked to peptide covalently attached via linking group to second solid support linked to oligonucleotide, wherein supports are beads covalently attached by heterobifunctional crosslinking agent
07/09/2002US6416946 Contacting sample with composition comprising reagent consisting essentially of combination of hepatitis c type specific epitopes under conditions which allow formation of epitope-antibody complexes, assaying for presence of complexes
07/09/2002US6416945 Disassembling virus-like particles of l1 proteins or mixture of l1 and l2 proteins by contacting for prolonged time period with concentrated reducing agent solution, adding moiety to be encapsulated, reassembling by removing reducing agent
07/09/2002US6416944 Methods of typing hepatitis C virus and reagents for use therein
07/09/2002US6416758 Antibody conjugate kits for selectively inhibiting VEGF
07/09/2002CA2363662A1 Sequences and methods for detection of hiv-1
07/09/2002CA2264189C Homocysteine desulphurase from the protozoan trichomonas vaginalis
07/09/2002CA2186021C Purified dna polymerase from bacillus stearothermophilus
07/09/2002CA2133845C Adrenocorticotrophic hormone receptor and uses
07/09/2002CA2108895C Genetic control of acetylation and pyruvylation of xanthan based polysaccharide polymers
07/09/2002CA2077434C Antigenic proteins of borrelia burgdorferi
07/09/2002CA2042236C Seroreactive epitopes on proteins of human papillomavirus (hpv) 18
07/09/2002CA2040707C Cephalosporin acetylhydrolase gene and protein encoded by said gene
07/05/2002CA2352498A1 .beta.1,3- galactosyltransferase and dna encoding the same
07/04/2002WO2002052273A1 Screening method based on siah-numb interaction
07/04/2002WO2002052268A1 A screening assay for antagonists of human leukocyte receptors
07/04/2002WO2002052266A1 Method of binding nucleic acid to diamond, diamond-mononucleoside conjugate and diamond-nucleic acid conjugate
07/04/2002WO2002052259A1 Rapid and quantitative proteome analysis and related methods
07/04/2002WO2002052046A2 Oligonucleotide transfection screening method
07/04/2002WO2002052039A2 Methods for selecting and producing pharmaceutical compounds using a library responsive to transcription factors
07/04/2002WO2002052036A2 Identification of modulators of dham-kinase and inflammatory diseases
07/04/2002WO2002052029A1 Process for producing recombinant protein and fused protein
07/04/2002WO2002052026A2 Nucleic acid integration in eukaryotes
07/04/2002WO2002052025A2 Plant transformation process with selection and early identification of germline events
07/04/2002WO2002052024A2 Elongase promoters
07/04/2002WO2002052023A2 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
07/04/2002WO2002052022A2 Selective cytotoxic fusion proteins
07/04/2002WO2002052021A1 Thermostable l-arabinose isomerase and process for preparing d-tagatose thereby
07/04/2002WO2002052020A2 Regulation of human carboxypeptidase a
07/04/2002WO2002052019A2 22437, a human sulfatase and uses therefor
07/04/2002WO2002052018A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/04/2002WO2002052017A1 Process for producing coenzyme q¿10?
07/04/2002WO2002052016A2 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
07/04/2002WO2002052015A2 Self-replicating rna molecule from hepatitis c virus
07/04/2002WO2002052014A2 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells
07/04/2002WO2002052013A2 The flu gene: a tool for the identification of genes involved in stress responses and apoptosis and a target for herbicides specific for angiosperms
07/04/2002WO2002052012A2 Sugar beet genes involved in stress tolerance
07/04/2002WO2002052011A2 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1
07/04/2002WO2002052010A1 Estrogen receptor genes and utilization thereof
07/04/2002WO2002052009A1 Human fgf23 protein mutant lowering blood phosphorus level
07/04/2002WO2002052008A1 Novel cancer-associated genes
07/04/2002WO2002052007A1 Synovial membrane cell protein
07/04/2002WO2002052006A1 Method of examining allergic disease
07/04/2002WO2002052005A1 Novel genes and proteins encoded thereby
07/04/2002WO2002052004A1 Gene involved in apoptosis regulation
07/04/2002WO2002052003A2 Regulation of human calcium channel
07/04/2002WO2002052002A2 Immunomodulatory polynucleotides and methods of using the same
07/04/2002WO2002052001A1 Method of identifying dna encoding physiologically active polypeptide in mammalian body
07/04/2002WO2002052000A1 Novel potassium channel
07/04/2002WO2002051997A1 Methods for cloning mammals using reprogrammed donor chromatin or donor cells
07/04/2002WO2002051994A2 Polypeptides
07/04/2002WO2002051992A2 21163, a novel human prolyl oligopeptidase and uses therefor
07/04/2002WO2002051990A2 Proteases of endogenous retroviruses, substrates thereof and method for screening inhibitors
07/04/2002WO2002051989A2 Human 4-nitrophenylphosphatase
07/04/2002WO2002051988A2 Thymic epithelial progenitor cells and uses thereof
07/04/2002WO2002051987A1 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
07/04/2002WO2002051982A2 Bacterial promoters and methods of use
07/04/2002WO2002051981A2 Defects in periaxin associated with myelinopathies
07/04/2002WO2002051978A2 Yeasts transformed by genes enhancing their cold stress tolerance
07/04/2002WO2002051871A2 Anti-cd28 antibody
07/04/2002WO2002051870A2 Phage display libraries of human vh fragments
07/04/2002WO2002051869A1 Compounds comprising two or more identical protein domains interlinked by a peptide having such a length that each of the protein domains can interact simultaneously with its specific cell-surface structure and thereby block the function of the structure
07/04/2002WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
07/04/2002WO2002051866A2 Antibacterial treatments
07/04/2002WO2002051864A1 Protein cluster ii
07/04/2002WO2002051858A2 Antisense modulation of chk2 expression
07/04/2002WO2002051856A2 Method for immobilising probes, in particular for producing biochips
07/04/2002WO2002051800A2 Sulphur-containing amphiphilic agents for the transfer of biologically active molecules into cells
07/04/2002WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling
07/04/2002WO2002051355A2 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action
07/04/2002WO2002051351A2 Antithrombotic von willebrand factor (vwf) collagen bridging blockers
07/04/2002WO2002051238A2 Recombinant dna vectors for expression of somatotropins
07/04/2002WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof
07/04/2002WO2002051231A1 Genes of corynebacterium
07/04/2002WO2002036738A3 Affinity maturation by competitive selection
07/04/2002WO2002033116A3 Nucleic acid ligands to the prostate specific membrane antigen
07/04/2002WO2002033100A3 Regulation of human adenylate cyclase, type iv
07/04/2002WO2002031113A3 Enhanced selection of genetically modified pine embryogenic tissue